| Name | Title | Contact Details |
|---|
Selena Group is a leading global manufacturer of construction chemicals and polyurethane foam, established in 1992 and based in Wrocław, Poland. The company operates in 18–19 countries with around 1,800–2,000 employees and has 30–35 subsidiaries, including manufacturing facilities in Poland, South Korea, China, Romania, Turkey, Spain, Kazakhstan, and Italy. Selena Group is recognized as one of the top four manufacturers of assembly foam and a significant distributor of construction chemicals. Its product range includes high-yield polyurethane foams, sealants, adhesives, waterproofing systems, and thermal insulation solutions. The company operates through four specialized divisions: Interior & Decorations, Windows & Doors, Waterproofing, and Walls, Facades & Chemical Constructions. Selena serves 100 markets worldwide, focusing on professional contractors, industrial users, and home builders, while emphasizing sustainability and innovation in its offerings.
Carve Designs is a beach lifestyle brand committed to making clothes for real women. We design surf-inspired active and lifestyle apparel that makes our customers feel feminine, sexy, natural and authentic. Based in Northern California, Carve Designs was founded by women.
Coast2Coast HR, LLC specializes in helping organizations with leadership development, leader coaching, group training, investigations, policy review, handbooks, recruitment services, and working with HR teams to better align them to business expectations. We also work directly with HR departments to help them meet their expectations. Our senior-level team members assess the current state of the department, make recommendations to address concerns, and take action on the approved plan. Once the department meets its goals, we can recruit a replacement if required, and the contract will be complete. Our estimated timelines are 6 to 12 months.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
Cox PLLC exists to serve you and your company. We are litigators, counselors and trial attorneys. Our clients hire us to aggressively preserve or grow equity, eliminate risk and resolve disputes. We are available anytime and anywhere.